An Evaluation of a New Quantitative Point-of Care Diagnostic to Measure Glucose-6-phosphate Dehydrogenase Activity
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Malaria continues to be one of the most crucial infectious burdens in endemic areas worldwide, as well as for travelers visiting malaria transmission regions. It has been reported that 8-aminoquinolines are effective against the Plasmodium species, particularly primaquine, for anti-hypnozoite therapy in P. vivax malaria. However, primaquine causes acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Therefore, G6PD deficiency testing should precede hypnozoite elimination with 8-aminoquinoline. Several point-of-care devices have been developed to detect G6PD deficiency. The aim of the present study was to evaluate the performance of a novel, quantitative G6PD diagnostics based on a metagenomic blue fluorescent protein (mBFP). We comparatively evaluated the sensitivity and specificity of the G6PD diagnostic modality with standard methods using 120 human whole blood samples. The G6PD deficiency was spectrophotometrically confirmed. The performance of the G6PD quantitative test kit was compared with that of a licensed control medical device, the G6PD strip. The G6PD quantitative test kit had a sensitivity of 95% (95% confidence interval (CI): 89.3-100%) and a specificity of 100% (95% CI: 94.3-100%). This study shows that the novel diagnostic G6PD quantitative test kit could be a cost-effective and time-efficient, and universally mandated screening tool for G6PD deficiency.
Abstract
Malaria continues to be one of the most crucial infectious burdens in endemic areas worldwide, as well as for travelers visiting malaria transmission regions. It has been reported that 8-aminoquinolines are effective against the Plasmodium species, particularly primaquine, for anti-hypnozoite therapy in P. vivax malaria. However, primaquine causes acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Therefore, G6PD deficiency testing should precede hypnozoite elimination with 8-aminoquinoline. Several point-of-care devices have been developed to detect G6PD deficiency. The aim of the present study was to evaluate the performance of a novel, quantitative G6PD diagnostics based on a metagenomic blue fluorescent protein (mBFP). We comparatively evaluated the sensitivity and specificity of the G6PD diagnostic modality with standard methods using 120 human whole blood samples. The G6PD deficiency was spectrophotometrically confirmed. The performance of the G6PD quantitative test kit was compared with that of a licensed control medical device, the G6PD strip. The G6PD quantitative test kit had a sensitivity of 95% (95% confidence interval (CI): 89.3-100%) and a specificity of 100% (95% CI: 94.3-100%). This study shows that the novel diagnostic G6PD quantitative test kit could be a cost-effective and time-efficient, and universally mandated screening tool for G6PD deficiency.
참고문헌 (38)
- Robert C. Stanton, "Glucose-6-phosphate dehydrogenase, NADPH, and cell survival", IUBMB Life, 64(5), pp.362~369 (2012), Wiley[DOI]
- MD Cappellini, "Glucose-6-phosphate dehydrogenase deficiency", The Lancet, 371(9606), pp.64~74 (2008), Elsevier BV[DOI]
- Lucio Luzzatto, "Glucose-6-phosphate dehydrogenase deficiency", Blood, 136(11), pp.1225~1240 (2020), American Society of Hematology[DOI]
- Lucio Luzzatto, "The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics", The Lancet, 376(9742), pp.739~741 (2010), Elsevier BV[DOI]
- Jane F. Desforges, "Glucose-6-Phosphate Dehydrogenase Deficiency", New England Journal of Medicine, 324(3), pp.169~174 (1991), Massachusetts Medical Society[DOI]
- Philip J Mason, "G6PD deficiency: the genotype-phenotype association", Blood Reviews, 21(5), pp.267~283 (2007), Elsevier BV[DOI]
- Nick Carter, "Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials", Malaria Journal, 10(1), pp.241~ (2011), Springer Science and Business Media LLC[DOI]
- R. Q. Blackwell, "Low Incidence of Erythrocyte G-6-PD Deficiency in Koreans", Vox Sanguinis, 14(4), pp.299~303 (1968), Wiley[DOI]
- Youn-Kyoung Goo, "First Evaluation of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in Vivax Malaria Endemic Regions in the Republic of Korea", PLoS ONE, 9(5), pp.e97390~ (2014), Public Library of Science (PLoS)[DOI]
- Carmencita D. Padilla, "Newborn screening in the Asia Pacific region", Journal of Inherited Metabolic Disease, 30(4), pp.490~506 (2007), Wiley[DOI]
- Rosalind E. Howes, "G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based Map", PLoS Medicine, 9(11), pp.e1001339~ (2012), Public Library of Science (PLoS)[DOI]
- Aldiouma Guindo, "X-Linked G6PD Deficiency Protects Hemizygous Males but Not Heterozygous Females against Severe Malaria", PLoS Medicine, 4(3), pp.e66~ (2007), Public Library of Science (PLoS)[DOI]
- F. Nowell Jones, "Space-Time Relationships in Somesthetic Localization", Science, 124(3220), pp.484~484 (1956), American Association for the Advancement of Science (AAAS)[DOI]
- Beutler E, "G6PD deficiency working group. Glucose-6-phosphate dehydrogenase deficiency and antimalaria drug development", Am J Trop Med Hyg, 77, pp.779~789 (2007)
- Julie Jensen DelFavero, "Glucose-6-Phosphate Dehydrogenase Deficiency and the Benefits of Early Screening", Neonatal Network, 39(5), pp.270~282 (2020), Springer Publishing Company[DOI]
- Wojciech A. Krotoski, "Discovery of the hypnozoite and a new theory of malarial relapse", Transactions of the Royal Society of Tropical Medicine and Hygiene, 79(1), pp.1~11 (1985), Oxford University Press (OUP)[DOI]
- Judith Recht, "Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries", PLOS Neglected Tropical Diseases, 12(4), pp.e0006230~ (2018), Public Library of Science (PLoS)[DOI]
- Wonsig Lee, "Investigation of glucose-6-phosphate dehydrogenase (G6PD) deficiency prevalence in a Plasmodium vivax-endemic area in the Republic of Korea (ROK)", Malaria Journal, 19(1), pp.317~ (2020), Springer Science and Business Media LLC[DOI]
- 이재웅, "Genetic Profiles of Korean Patients With Glucose-6-Phosphate Dehydrogenase Deficiency", Annals of Laboratory Medicine, 37(2), pp.108~116 (2017), 대한진단검사의학회
- "Korean Social Trends 2019 (11-1240245-00014-10)"[URL]
- Bahk Young Yil, "A Profile of Glucose-6-Phosphate Dehydrogenase Variants and Deficiency of Multicultural Families in Korea", Parasites, Hosts and Diseases, 59(5), pp.447~455 (2021), 대한기생충학ㆍ열대의학회[DOI]
- 이혜경, "혼인이주와 혼인이주 가정의 문제와 대응", 한국인구학, 28(1), pp.73~106 (2005), 한국인구학회
- "Current status of foreign residents"[URL]
- Oh JE, "Migration Profile of the Republic of Korea" (2012), IOM Migration Research and Training Center
- Athena Anderle, "Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening", International Journal of Neonatal Screening, 4(4), pp.34~ (2018), MDPI AG[DOI]
- Martin P Grobusch, "The Primaquine Problem—and the Solution? Point-of-care Diagnostics for Glucose 6–Phosphate Dehydrogenase Deficiency", Clinical Infectious Diseases, 69(8), pp.1443~1445 (2019), Oxford University Press (OUP)[DOI]
- Oum Kelthoum Mamadou Djigo, "Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania", Infectious Diseases of Poverty, 10(1), pp.105~ (2021), Springer Science and Business Media LLC[DOI]
- "Standardization of Procedures for The Study of Glucose-6-Phosphate Dehydrogenase" (1967)[URL]
- Benedikt Ley, "A Comparison of Three Quantitative Methods to Estimate G6PD Activity in the Chittagong Hill Tracts, Bangladesh", PLOS ONE, 12(1), pp.e0169930~ (2017), Public Library of Science (PLoS)[DOI]
- Domingo GJ, "G6PD testing in support of treatment and elimination of malaria : recommendations for evaluation of G6PD tests", Malaria J, 12, pp.391~ (2013)[DOI]
- Pairat Pengboon, "Evaluation of quantitative biosensor for glucose-6-phosphate dehydrogenase activity detection", PLOS ONE, 14(12), pp.e0226927~ (2019), Public Library of Science (PLoS)[DOI]
- Kornberg A, "Methods in Enzymology Volume 1", pp.323~ (1955), Academic Press
- Georg Wilhelm Löhr, "Glucose-6-phosphate Dehydrogenase", Methods of Enzymatic Analysis, pp.636~643 (1974), Elsevier[DOI]
- Roshanzadeh A, "Real-time monitoring of NADPH levels in living mammalian cells using fluorescence-enhancing protein bound to NADPHs", Biosens Bioelectron, 146, pp.111753~ (2019)[DOI]
- Hwang CS, "Screening of a highly soluble and oxygen-independent blue fluorescence protein from metagenome", Biochem Biophys Res Comm, 419, pp.676~681 (2012)[DOI]
- Seo PW, "Structure-guided genereation of redox-independent blue fluorescence protein from mBFP", J Mol Biol, 431, pp.3191~3202 (2019)[DOI]
- Sung-Hwan You, "Rapid and sensitive detection of NADPH via mBFP-mediated enhancement of its fluorescence", PLOS ONE, 14(2), pp.e0212061~ (2019), Public Library of Science (PLoS)[DOI]
- K. L. Kavanagh, "Medium- and short-chain dehydrogenase", reductase gene and protein families, 2008, pp.65(24), 3895~3906[DOI]
